"Hemolysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Descriptor ID |
D006461
|
| MeSH Number(s) |
C23.550.403 G12.122.545
|
| Concept/Terms |
Extravascular Hemolysis- Extravascular Hemolysis
- Extravascular Hemolyses
- Hemolyses, Extravascular
- Hemolysis, Extravascular
Intravascular Hemolysis- Intravascular Hemolysis
- Hemolyses, Intravascular
- Hemolysis, Intravascular
- Intravascular Hemolyses
|
Below are MeSH descriptors whose meaning is more general than "Hemolysis".
Below are MeSH descriptors whose meaning is more specific than "Hemolysis".
This graph shows the total number of publications written about "Hemolysis" by people in this website by year, and whether "Hemolysis" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 4 | 5 |
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 3 | 4 |
| 1998 | 1 | 1 | 2 |
| 1999 | 4 | 3 | 7 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 3 | 4 |
| 2003 | 0 | 5 | 5 |
| 2004 | 2 | 8 | 10 |
| 2005 | 3 | 9 | 12 |
| 2007 | 1 | 7 | 8 |
| 2008 | 3 | 4 | 7 |
| 2009 | 0 | 6 | 6 |
| 2010 | 1 | 6 | 7 |
| 2011 | 4 | 5 | 9 |
| 2012 | 2 | 9 | 11 |
| 2013 | 2 | 6 | 8 |
| 2014 | 4 | 6 | 10 |
| 2015 | 5 | 3 | 8 |
| 2016 | 1 | 4 | 5 |
| 2017 | 3 | 6 | 9 |
| 2018 | 7 | 9 | 16 |
| 2019 | 7 | 4 | 11 |
| 2020 | 4 | 9 | 13 |
| 2021 | 4 | 6 | 10 |
| 2022 | 3 | 8 | 11 |
| 2023 | 2 | 10 | 12 |
| 2024 | 6 | 5 | 11 |
| 2025 | 2 | 1 | 3 |
Below are the most recent publications written about "Hemolysis" by people in Profiles.
-
Evaluation of hemolysis in patients supported with Impella 5.5: a single center experience. J Cardiothorac Surg. 2025 Mar 01; 20(1):143.
-
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH. Blood. 2025 Feb 20; 145(8):811-822.
-
Increased exercise tolerance in humanized G6PD-deficient mice. Blood Adv. 2025 Jan 28; 9(2):321-334.
-
Hemolysis due to anti-IH in a patient with beta-thalassemia and Mycoplasma pneumoniae infection. Immunohematology. 2024 Dec 01; 40(4):139-144.
-
Effect of voxelotor on cerebral perfusion and cerebral oxygen metabolism and cardiac stress in adult patients with sickle cell disease. Am J Hematol. 2025 Jan; 100(1):78-84.
-
Post-Artesunate Delayed Hemolysis in Pediatric Malaria Patients in the United States. J Pediatric Infect Dis Soc. 2024 Nov 04; 13(10):533-536.
-
Lysis of human erythrocytes due to Piezo1-dependent cytosolic calcium overload as a mechanism of circulatory removal. Proc Natl Acad Sci U S A. 2024 Sep 03; 121(36):e2407765121.
-
Biological and genetic determinants of glycolysis: Phosphofructokinase isoforms boost energy status of stored red blood cells and transfusion outcomes. Cell Metab. 2024 Sep 03; 36(9):1979-1997.e13.
-
Testosterone supplementation increases red blood cell susceptibility to oxidative stress, decreases membrane deformability, and decreases survival after cold storage and transfusion. Transfusion. 2024 Aug; 64(8):1469-1480.
-
Genetic regulation of carnitine metabolism controls lipid damage repair and aging RBC hemolysis in vivo and in vitro. Blood. 2024 06 13; 143(24):2517-2533.